Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage

AIMS: Cardiac transthyretin amyloidosis (ATTR‐CM) is a progressive and fatal condition. Prognosis can be determined at diagnosis according to the National Amyloidosis Centre (NAC) transthyretin amyloidosis (ATTR) stage. We sought to examine how NAC ATTR stage changes during follow‐up and whether it...

Descripción completa

Detalles Bibliográficos
Autores principales: Law, Steven, Petrie, Aviva, Chacko, Liza, Cohen, Oliver C., Ravichandran, Sriram, Gilbertson, Janet A., Rowczenio, Dorota, Wechalekar, Ashutosh, Martinez‐Naharro, Ana, Lachmann, Helen J., Whelan, Carol J., Hutt, David F., Hawkins, Philip N., Fontana, Marianna, Gillmore, Julian D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755026/
https://www.ncbi.nlm.nih.gov/pubmed/32924285
http://dx.doi.org/10.1002/ehf2.12989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755026/
https://www.ncbi.nlm.nih.gov/pubmed/32924285
http://dx.doi.org/10.1002/ehf2.12989

Ejemplares similares